Novartis AG (NEO:NVS)

Canada flag Canada · Delayed Price · Currency is CAD
23.32
0.00 (0.00%)
Sep 26, 2025, 4:00 PM EDT
Market Cap332.76B
Revenue (ttm)75.27B
Net Income (ttm)18.62B
Shares Outn/a
EPS (ttm)9.34
PE Ratio17.87
Forward PE14.44
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume7,584
Open23.32
Previous Close23.32
Day's Range23.32 - 23.32
52-Week Range20.11 - 24.09
Betan/a
RSI54.56
Earnings DateOct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy... [Read more]

Sector Healthcare
Founded 1996
Employees 75,883
Stock Exchange Cboe Canada
Ticker Symbol NVS
Full Company Profile

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.